Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy
Open Access
- 23 November 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 54 (2), 322-329
- https://doi.org/10.1093/jrr/rrs108
Abstract
The purpose of this study was to assess the efficacy and toxicity of definitive radiotherapy (RT) for the recurrence of epithelial ovarian cancer, which is limited to one or two gross regions, after complete remission had been achieved with aggressive front-line therapy. Twenty-seven patients were treated with definitive RT and were retrospectively analyzed. Their median tumor size was 3.0 cm. Twenty-six (96%) patients received external irradiation at a median total dose of 60 Gy, and a median daily dose of 2 Gy. Only two patients received intracavitary brachytherapy. Twenty (74%) of the 27 patients received systemic chemotherapy for the treatment of a limited recurrent tumor followed by definitive RT. Six (22%) of the patients received concurrent chemotherapy and seven (26%) of the patients also underwent regional hyperthermia during definitive RT. Twenty-two (82%) patients had an objective response (CR: 11, PR: 11). The 2-year overall survival, progression-free survival and local (in-field) control rates after RT were 53%, 39% and 96%, respectively. The toxicities were mild, no Grade 3 or higher toxicity was observed in any of the patients. The tumor size( < 3 cm), period between front-line therapy and RT (≥2 year) and objective tumor response (CR) were significant prognostic factors of the overall survival rate. In conclusion, definitive RT for limited recurrence of epithelial ovarian cancer achieves a better local control rate without severe toxicity, and it may therefore be a potentially effective modality for inducing long-term survival in selected patients.Keywords
This publication has 23 references indexed in Scilit:
- Stereotactic Body Radiotherapy for Oligometastatic Lung TumorsInternational Journal of Radiation Oncology*Biology*Physics, 2008
- A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesionsCancer, 2007
- Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancerGynecologic Oncology, 2005
- Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapyInternational Journal of Gynecologic Cancer, 2002
- Selective Irradiation for the Treatment of Recurrent Ovarian Carcinoma Involving the Vagina or RectumGynecologic Oncology, 2001
- Second-Line Treatment of Ovarian CancerThe Oncologist, 2000
- Palliative Benefit of External-Beam Radiation in the Management of Platinum Refractory Epithelial Ovarian CarcinomaGynecologic Oncology, 1998
- Salvage whole-abdominal irradiation following chemotherapy failure in epithelial ovarian carcinomaGynecologic Oncology, 1990
- Concurrent chemotherapy and single high-dose plus whole abdominopelvic radiation for persistent ovarian carcinomaGynecologic Oncology, 1989
- Advanced epithelial ovarian cancer: Toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperationGynecologic Oncology, 1986